XML 55 R18.htm IDEA: XBRL DOCUMENT v3.19.2
STOCKHOLDERS' EQUITY
6 Months Ended
Aug. 31, 2019
Equity [Abstract]  
STOCKHOLDERS' EQUITY

NOTE 12 – STOCKHOLDERS’ EQUITY

Stock Repurchase

On December 10, 2018, our Board of Directors authorized a new share repurchase program under which we may repurchase up to $20.0 million of our outstanding common stock over the next 12 months, of which $10.0 million was utilized as of February 28, 2019. Under the stock repurchase program, we may repurchase shares in the open market. There were no stock repurchases during the six months ended August 31, 2019.

 

Employee Stock Purchase Plan

 

On June 7, 2018, our Board of Directors adopted the CalAmp Corp. 2018 Employee Stock Purchase Plan (the “ESPP”), which was approved by our stockholders on July 25, 2018. The ESPP provides for the issuance of 1,750,000 shares of our common stock. The first enrollment under the ESPP Plan commenced in February 2019. There are two enrollment periods each year that commence on February 1st and August 1st and lasts for six months. Stock-based compensation expense related to the ESPP for the three and six months ended August 31, 2019 was $0.2 million and $0.3 million, respectively.

 

Equity Awards

Stock-based compensation expense is included in the following captions of the condensed consolidated statements of comprehensive income (loss) (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

August 31,

 

 

August 31,

 

 

 

2019

 

 

2018

 

 

2019

 

 

2018

 

Cost of revenues

 

$

162

 

 

$

212

 

 

$

337

 

 

$

389

 

Research and development

 

 

633

 

 

 

420

 

 

 

1,046

 

 

 

785

 

Selling and marketing

 

 

982

 

 

 

680

 

 

 

1,651

 

 

 

1,251

 

General and administrative

 

 

1,406

 

 

 

1,368

 

 

 

2,692

 

 

 

2,722

 

 

 

$

3,183

 

 

$

2,680

 

 

$

5,726

 

 

$

5,147

 

 

Changes in our outstanding stock options during the six months ended August 31, 2019 were as follows (options in thousands):

 

 

 

Number of

Options

 

 

Weighted

Average

Exercise Price

 

 

Weighted average remaining contractual life (years)

 

 

Aggregate intrinsic value

 

Outstanding at February 28, 2019

 

 

1,054

 

 

$

13.44

 

 

 

5.8

 

 

 

 

 

Granted

 

 

171

 

 

 

11.11

 

 

 

 

 

 

 

 

 

Exercised

 

 

(83

)

 

 

2.36

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at August 31, 2019

 

 

1,142

 

 

$

13.90

 

 

 

6.3

 

 

$

1,349

 

Exercisable at August 31, 2019

 

 

717

 

 

$

12.20

 

 

 

4.8

 

 

$

1,349

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in our outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the six months ended August 31, 2019 were as follows (restricted shares, PSUs and RSUs in thousands):

 

 

 

Number of Restricted

Shares, PSUs

and RSUs

 

 

Weighted

Average Grant

Date Fair Value

 

 

Shares Retained to Cover Statutory Minimum Withholding Taxes

 

Outstanding at February 28, 2019

 

 

1,507

 

 

$

19.77

 

 

 

 

 

Granted

 

 

1,544

 

 

 

11.30

 

 

 

 

 

Vested

 

 

(441

)

 

 

18.91

 

 

 

150

 

Forfeited

 

 

(96

)

 

 

20.04

 

 

 

 

 

Outstanding at August 31, 2019

 

 

2,514

 

 

$

14.69

 

 

 

 

 

 

As of August 31, 2019, there was $36.4 million of total unrecognized stock-based compensation cost related to outstanding nonvested equity awards that is expected to be recognized as an expense over a weighted-average remaining vesting period of 3.3 years.